Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Propanc Biopharma Inc (PPCB)
:PPCB
Holding PPCB?
Track your performance easily
PPCB Stock Chart & Stats
Day’s Range― - ―
52-Week Range$0.01 - $0.01
Previous CloseN/A
Volume127.03K
Average Volume (3M)9.41M
Market Cap
$157.98K
Enterprise ValueN/A
Total Cash (Recent Filing)$69.04K
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)―
Beta0.67
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.04
Shares Outstanding789,899,200
10 Day Avg. Volume3,701,758
30 Day Avg. Volume9,414,742
Standard Deviation0.48
R-Squared0.04
Alpha-0.22
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)-0.20
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
PPCB FAQ
What was Propanc Biopharma Inc’s price range in the past 12 months?
Propanc Biopharma Inc lowest stock price was $0.01 and its highest was $0.01 in the past 12 months.
What is Propanc Biopharma Inc’s market cap?
Propanc Biopharma Inc’s market cap is $157.98K.
When is Propanc Biopharma Inc’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Propanc Biopharma Inc’s earnings last quarter?
Propanc Biopharma Inc released its earnings results on Feb 14, 2020. The company reported -$1250780 earnings per share for the quarter, missing the consensus estimate of N/A by -$1250780.
Is Propanc Biopharma Inc overvalued?
According to Wall Street analysts Propanc Biopharma Inc’s price is currently Overvalued.
Does Propanc Biopharma Inc pay dividends?
Propanc Biopharma Inc does not currently pay dividends.
What is Propanc Biopharma Inc’s EPS estimate?
Propanc Biopharma Inc’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Propanc Biopharma Inc have?
Propanc Biopharma Inc has 789,899,200 shares outstanding.
What happened to Propanc Biopharma Inc’s price movement after its last earnings report?
Propanc Biopharma Inc reported an EPS of -$1250780 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went same N/A.
Which hedge fund is a major shareholder of Propanc Biopharma Inc?
Currently, no hedge funds are holding shares in PPCB
---
Company Description
Propanc Biopharma Inc
Propanc Biopharma, Inc. is a development-stage healthcare company, which engages in the research and development of cancer treatments. The company focuses on the treatment of pancreatic, ovarian, and colorectal cancer. It offers its product pipeline, including PRP and POP1. The company was founded by James Nathanielsz and Julian Kenyon on October 15, 2007 and is headquartered in Camberwell, Australia.
---
Cellectar Biosciences
―
Advaxis
―
Cyclacel Pharmaceuticals
―
Plus Therapeutics
―
Agenus
―
Anavex Life Sciences
―
---